BCL2 and central nervous system cancer: Yang et al. have shown that miRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway or possibly through one of the putative target genes, Zyxin [38-40].